Cisplatin and creatinine clearance
WebAug 30, 2024 · Cisplatin Injection, is a clear, light-yellow, sterile aqueous solution, for intravenous use, available in sterile multiple-dose vials containing - 50 mg/50 mL (1 mg/mL) 100 mg/100 mL (1 ... 4 CONTRAINDICATIONS Cisplatin Injection is contraindicated in patients with severe hypersensitivity to cisplatin [see Warnings and Precautions (5.4)].
Cisplatin and creatinine clearance
Did you know?
WebFeb 16, 2016 · All patients were treated with high-dose cisplatin CCRT. The main outcome parameters were nephrotoxicity (defined as creatinine clearance grade 2 or more) and … WebFeb 9, 2024 · Creatinine clearance is a measure of how well the kidneys filter creatinine out of the bloodstream for excretion in urine. Creatinine clearance is usually determined …
WebSep 4, 2013 · The dose of cisplatin was reduced by 25% in all the subsequent cycles if the serum creatinine level increased to Grade 2 or higher. Statistical Analyses This study was designed as a nonrandomized, single-center Phase II trial. WebApr 19, 2024 · Cisplatin is a heavy metal complex containing a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. It is soluble in water or saline at 1 mg/mL and in dimethylformamide at 24 mg/mL. It has a melting point of 207° C Indications & Dosage INDICATIONS Advanced Testicular Cancer
WebBackground A strategy for preventing cisplatin nephrotoxicity due to enhanced oxidative stress and inflammatory response is highly desirable. Thioredoxin-1 (Trx), an endogenous redox-active protein, WebThe manufacturer recommends withholding repeat administration of the drug until the serum creatinine concentration is ,1.5 mg/dL. Cisplatin has been suc- cessfullyadministeredtoHDpatientswithsimilartoleranceasin patients with normal renal …
WebEstimating GFR with the aMDRD formula and adding an intermediary level of dose reduction for patients with eGFR from 50 to 59.9 mL/min may result in a higher cumulative …
WebRegression analysis of the data showed two phases of long-term renal platinum excretion, one occurring at between 150 and 900 days of follow-up and the other with an onset at … flowfusor irrigationWebJul 22, 2024 · Cisplatin is a potent and valuable chemotherapy agent used to treat a broad spectrum of malignancies. Renal tubular dysfunction and a cumulative impairment in kidney function, as manifested by a decline in the glomerular filtration rate (GFR), can be dose … green card holder can travel to europeWebNo significant relationship of serum creatinine levels, creatinine clearance levels, or of their increments or decrements to cisplatin dose intensity or accumulated dose were found. These levels also did not correlate with age, sex, comorbidity or Eastern Cooperative Oncology Group score. green card holder coming back to usaWebAug 31, 2024 · The recommended dose of ALIMTA when administered with cisplatin for initial treatment of locally advanced or metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m 2 as an intravenous infusion over 10 minutes administered prior to cisplatin … flowfushi lip 38 c lip treatmentWebHigher cisplatin delivery rates led to higher peak concentrations of free Pt in plasma and urine and to lower cumulative renal Pt elimination (P < 0.01). During all courses, increases of urinary albumin and alpha1-microglobulin excretion were documented. The creatinine clearance decreased significantly to 70% of baseline values. flow fusion bindingsWebA repeat course of cisplatin should not be given until: the serum creatinine is below 140micromol/L and/or the plasma urea is below 9mmol/L and circulating blood elements are at an acceptable level (platelets at least 100,000/mm3, WBC at least 4000/mm3). A base line audiogram should be taken and the patient monitored periodically for auditory green card holder constitutional rightsWebApr 12, 2024 · Among conventional chemotherapeutic drugs, cisplatin deserves a special mention. This drug is the most commonly used in cancer treatment and it can induce nephrotoxic side effects by tubular damage . ... Indeed, from 5% to 15% of the patients with both estimated creatinine clearance (eCrCl), expressed in milliliters/minute, ... flow fusion welding